Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients
Clinical trial NCT00453635 · TERMINATED
Trial details
- NCT number
- NCT00453635
- Sponsor
- Hellenic Oncology Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2008-11-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.